MEDIBEACON INC.
Transdermal GFR assessment system using Lumitrace tracer agent for non-invasive kidney function measurement
- Sector
- Medtech
- Headquarters
- SAINT LOUIS, MO
- Founded
- 2012
- Latest Form D
- $16.1M, Jan 2025
- Total capital
- $87.9M
- Federal grants
- $363K
- 2 awards · 2016
- Rank in peer group#22 of 23
- Private capital raised
- $87.5M
- 10 Form D · last Jan 2025
- 21 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 29
- 11 pending · first 2021
- Rank in peer group#1 of 23
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 10th filing$16.1M
- Private capital raisedForm D · SEC · 9th filing$1.8M
- Private capital raisedForm D · SEC · 8th filing$8.1M
- Private capital raisedForm D · SEC · 7th filing$34.3M
- Private capital raisedForm D · SEC · 6th filing$1.3M
- Private capital raisedForm D · SEC · 5th filing$2.1M
- Private capital raisedForm D · SEC · 4th filing$4.6M
- Private capital raisedForm D · SEC · 3rd filing$11.2M
- Private capital raisedForm D · SEC · 2nd filing$3M
- Private capital raisedForm D · SEC · 1st filing$5.1M
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Development of MB-102 as fluorescent tracer for ocular angiography$182K
- Federal grantHealth and Human S · Phase I · Development of MB-102 as fluorescent tracer for ocular angiography$182K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 23 peers
Line = medianMedtech · Molecule
- Federal grantsBelow median
- Granted patents#1 · top 4%
- Linked publications#1 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Richard DorshowResearcherExecutive Officer, DirectorLinked by 1 patent · $182K in grants as PI
- Charles B. BoltenDirectorNamed in SEC Form D filings
- Cherine PlumakerDirectorNamed in SEC Form D filings
- David PresentDirectorNamed in SEC Form D filings
- John A. FrielDirectorNamed in SEC Form D filings
- Richard A. LytleDirectorNamed in SEC Form D filings
Show all 10 people
- Steve HanleyExecutive Officer, DirectorNamed in SEC Form D filings
- Steven HanleyExecutive Officer, DirectorNamed in SEC Form D filings
- Steven MillerDirectorNamed in SEC Form D filings
- Terence SternExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 29 granted of 40- GrantedMethod For Preparing 3,6-DIAMINOPYRAZINE-2,5-DICARBOXYLIC Acid And Synthetic Intermediate ThereofUSPTOUS 12,692,240
- PendingMonitoring Time-varying Fluorescence Emitted From An Exogenous Fluorescence AgentUSPTOApplication 19340233
- GrantedPurification Of Substituted Diaminopyrazine Dicarboxylic AcidsUSPTOUS 12,428,382
Show all 40 patent records
- Method For Preparing 3,6-DIAMINOPYRAZINE-2,5-DICARBOXYLIC Acid And Synthetic Intermediate ThereofJul 28, 2026 · US 12,692,240Granted
- Monitoring Time-varying Fluorescence Emitted From An Exogenous Fluorescence AgentApr 16, 2026 · Application 19340233Pending
- Purification Of Substituted Diaminopyrazine Dicarboxylic AcidsSep 30, 2025 · US 12,428,382Granted
- Preparation Of Substituted Diaminopyrazine Dicarboxylic AcidsJun 3, 2025 · US 12,319,660Granted
- Compositions And Methods For Assessing Eye VasculatureMay 20, 2025 · US 12,303,570Granted
- Intrinsic Fluorescence Generation Using Exogenous Fluorescence AgentMar 27, 2025 · Application 18897554Pending
- Transcutaneous Organ Function MeasurementMar 25, 2025 · US 12,257,027Granted
- Method For Non-invasive Monitoring Of Fluorescent Tracer Agent With Diffuse Reflecting Medium With Time-varying Optical PropertiesMar 25, 2025 · US 12,257,048Granted
- SensorNov 26, 2024 · US D1,052,412Granted
- Sensor RingNov 19, 2024 · US D1,051,738Granted
- Uses Of Transdermal Glomerular Filtration Rate Measurement In Continuous Renal Replacement TherapyOct 1, 2024 · US 12,102,432Granted
- Compositions And Methods For Assessing Gut FunctionJul 30, 2024 · US 12,048,751Granted
- Transcutaneous Organ Function MeasurementJul 16, 2024 · US 12,036,022Granted
- Synthesis Of Substituted PyrazinesJun 6, 2024 · Application 18520826Pending
- Systems And Methods For Home Transdermal Assessment Of Gastrointestinal FunctionApr 30, 2024 · US 11,969,268Granted
- Method For Non-invasive Monitoring Of Fluorescent Tracer Agent With Diffuse Reflecting Medium With Time-varying Optical PropertiesApr 9, 2024 · US 11,950,907Granted
- Method For Preparing 3,6-DIAMINOPYRAZINE-2,5-DICARBOXYLIC Acid And Synthetic Intermediate ThereofJan 25, 2024 · Application 18036108Pending
- Anodic Oxidation Of 5-AMINOURACILJul 25, 2023 · US 11,708,336Granted
- Method For Preparing And Analyzing Fluorescent Compounds In PlasmaJun 13, 2023 · US 11,674,965Granted
- Compositions And Systems For Renal Function DeterminationJun 8, 2023 · Application 18162163Pending
- Methods For Renal Function DeterminationMay 25, 2023 · Application 18159253Pending
- Compositions And Systems For Renal Function DeterminationMar 14, 2023 · US 11,602,570Granted
- Methods For Renal Function DeterminationFeb 28, 2023 · US 11,590,244Granted
- Method For Non-invasive Monitoring Of Fluorescent Tracer Agent With Diffuse Reflecting Medium With Time-varying Optical PropertiesOct 25, 2022 · US 11,478,172Granted
- Methods Of Monitoring Mucosal HealingOct 13, 2022 · Application 17708789Pending
- Methods Of Using Optical AgentsJun 7, 2022 · US 11,351,274Granted
- Two Piece Sensor Assembly And Method Of UseMay 19, 2022 · Application 17650184Pending
- Subcutaneous And Intramuscular Administration Of Pyrazine CompoundsMay 12, 2022 · Application 17523659Pending
- Fluorescent Pyrazine Derivatives And Methods Of Using The Same In Assessing Renal FunctionApr 28, 2022 · Application 17646818Pending
- Compositions And Methods For Assessing Gut FunctionMar 29, 2022 · US 11,285,223Granted
- Compositions And Methods For Assessing Gut FunctionMar 29, 2022 · US 11,285,224Granted
- Two Piece Sensor Assembly And Method Of UseMar 1, 2022 · US 11,261,165Granted
- Sensor Assembly With Movable Skin SensorDec 2, 2021 · Application 17331341Pending
- Process For Using Optical AgentsNov 30, 2021 · US 11,185,597Granted
- Compositions And Methods For Assessing Eye VasculatureNov 2, 2021 · US 11,160,880Granted
- Transcutaneous Organ Function MeasurementSep 21, 2021 · US 11,122,979Granted
- Compositions And Methods For Assessing Gut FunctionAug 3, 2021 · US 11,077,211Granted
- Method For Non-invasive Monitoring Of Fluorescent Tracer Agent With Diffuse Reflection CorrectionsApr 20, 2021 · US 10,980,459Granted
- Tissue Sealant Compositions, Vascular Closure Devices, And Uses ThereofApr 6, 2021 · US 10,967,096Granted
- Tissue Sealant Compositions, Vascular Closure Devices, And Uses ThereofMar 30, 2021 · US 10,960,104Granted
Recent research by its founders
- Accuracy of Point-of-Care Transdermal GFR Methodology20260 cites
- A new kidney function assessment system utilizing a novel optical agent and its transdermal detection approved by the FDA20260 cites
- GFR Measurement Using Transdermal Detection Methodology202512 cites
Related companies, and why
- NANOPIN TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
- DS LABS, INC.Similar federal contract value in Medtech · null in contracts
- Curadel, LLCSimilar federal contract value in Medtech · null in contracts
- ARATOME, LLCSimilar federal contract value in Medtech · null in contracts
- Getinge ABSimilar federal contract value in Medtech · null in contracts
- Contra Healthcare Solutions, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .